Assertio Therapeutics
ASRT
#9523
Rank
S$96.9 M
Marketcap
S$1.01
Share price
-0.51%
Change (1 day)
-19.28%
Change (1 year)

Earnings for Assertio Therapeutics (ASRT)

Earnings in 2025 (TTM): -S$35.06 Million

According to Assertio Therapeutics 's latest financial reports the company's current earnings are S$0.13 Billion. In 2024 the company made an earning of -S$24.55 Million, an increase over its 2023 earnings that were of -S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Assertio Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$35.06 Million42.78%
2024 -S$24.55 Million-92.46%
2023 -S$0.33 Billion-744.93%
2022 S$50.49 M304.52%
2021 S$12.48 M-132.53%
2020 -S$38.38 Million-81.97%
2019 -S$0.22 Billion-253.57%
2018 S$0.13 B-451.81%
2017 -S$39.4 Million-258.05%
2016 S$24.92 M-138.59%
2015 -S$64.59 Million-121.01%
2014 S$0.30 B2275.01%
2013 S$12.94 M-133.45%
2012 -S$38.7 Million-141.87%
2011 S$92.4 M1496.17%
2010 S$5.78 M-121.23%
2009 -S$27.27 Million22.98%
2008 -S$22.17 Million-135.96%
2007 S$61.65 M
2003 -S$38.13 Million
2000 -S$10.04 Million43.5%
1999 -S$7 Million58.6%
1998 -S$4.41 Million580%
1997 -S$0.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-S$23.55 Million-31.08%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-S$0.21 Billion 505.39%๐Ÿ‡บ๐Ÿ‡ธ USA